- Home
- ANEB vs CDLX Comparison
ANEB vs CDLX Comparison
Compare ANEB & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- CDLX
- Stock Information
- Founded
- ANEB 2020
- CDLX 2008
- Country
- ANEB United States
- CDLX United States
- Employees
- ANEB N/A
- CDLX N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- CDLX Computer Software: Programming Data Processing
- Sector
- ANEB Health Care
- CDLX Technology
- Exchange
- ANEB Nasdaq
- CDLX Nasdaq
- Market Cap
- ANEB 102.7M
- CDLX 93.5M
- IPO Year
- ANEB 2021
- CDLX 2018
- Fundamental
- Price
- ANEB $2.60
- CDLX $1.11
- Analyst Decision
- ANEB Buy
- CDLX Hold
- Analyst Count
- ANEB 2
- CDLX 5
- Target Price
- ANEB $8.00
- CDLX $3.25
- AVG Volume (30 Days)
- ANEB 142.0K
- CDLX 1.4M
- Earning Date
- ANEB 09-24-2025
- CDLX 08-06-2025
- Dividend Yield
- ANEB N/A
- CDLX N/A
- EPS Growth
- ANEB N/A
- CDLX N/A
- EPS
- ANEB N/A
- CDLX N/A
- Revenue
- ANEB N/A
- CDLX $266,201,000.00
- Revenue This Year
- ANEB N/A
- CDLX N/A
- Revenue Next Year
- ANEB N/A
- CDLX $5.51
- P/E Ratio
- ANEB N/A
- CDLX N/A
- Revenue Growth
- ANEB N/A
- CDLX N/A
- 52 Week Low
- ANEB $0.80
- CDLX $0.95
- 52 Week High
- ANEB $3.42
- CDLX $5.25
- Technical
- Relative Strength Index (RSI)
- ANEB 57.46
- CDLX 36.47
- Support Level
- ANEB $2.22
- CDLX $0.95
- Resistance Level
- ANEB $2.69
- CDLX $1.32
- Average True Range (ATR)
- ANEB 0.20
- CDLX 0.14
- MACD
- ANEB -0.04
- CDLX -0.04
- Stochastic Oscillator
- ANEB 65.52
- CDLX 15.69
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.